A Director at Gilead Sciences is Exercising Options

By Carrie Williams

Today, a Director at Gilead Sciences, John Francis Cogan, exercised options of Gilead Sciences for $472.1K. The options were close to expired and John Francis Cogan disposed stocks.

In addition to John Francis Cogan, 5 other GILD executives reported Sell trades in the last month.

The company has a one-year high of $89.54 and a one-year low of $63.76. Currently, Gilead Sciences has an average volume of 7.59M. GILD’s market cap is $106B and the company has a P/E ratio of 23.29.

Based on 14 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $91.18, reflecting a -10.4% downside.

The insider sentiment on Gilead Sciences has been negative according to 84 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.